Lupin Liquidating Japan JV With Yoshindo, Partners With I’Rom For Denosumab Biosimilar

Also Receives UK Approval For Lutio Generic Version Of Spiriva

 
• By Vibha Ravi
  
Broken handshake
Lupin is liquidating its share in a Japanese biosimilars JV with Yoshindo • Source: Shutterstock: kuzmaphoto
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business